← All FR Documents
Notice

Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Request for Comment; National Roadside Survey of Alcohol and Drug Prevalence of Road Users: 2025

In Plain English

What is this Federal Register notice?

This is a notice published in the Federal Register by Transportation Department, National Highway Traffic Safety Administration. Notices communicate information, guidance, or policy interpretations but may not create new binding obligations.

Is this rule final?

This document is classified as a notice. It may or may not create enforceable regulatory obligations depending on its specific content.

Who does this apply to?

Consult the full text of this document for specific applicability provisions. The affected parties depend on the regulatory scope defined within.

When does it take effect?

No specific effective date is indicated. Check the full text for date provisions.

Why it matters: This notice communicates agency policy or guidance regarding applicable regulations.

Document Details

Document Number2025-18068
TypeNotice
PublishedSep 18, 2025
Effective Date-
RIN-
Docket IDDocket No. NHTSA-2025-0011
Text FetchedYes

Agencies & CFR References

CFR References:
None

Linked CFR Parts

PartNameAgency
No linked CFR parts

Paired Documents

TypeProposedFinalMethodConf
No paired documents

External Links

⏳ Requirements Extraction Pending

This document's regulatory requirements haven't been extracted yet. Extraction happens automatically during background processing (typically within a few hours of document ingestion).

Federal Register documents are immutable—once extracted, requirements are stored permanently and never need re-processing.

Full Document Text (2,399 words · ~12 min read)

Text Preserved
<NOTICE> DEPARTMENT OF TRANSPORTATION <SUBAGY>National Highway Traffic Safety Administration</SUBAGY> <DEPDOC>[Docket No. NHTSA-2025-0011]</DEPDOC> <SUBJECT>Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Request for Comment; National Roadside Survey of Alcohol and Drug Prevalence of Road Users: 2025</SUBJECT> <HD SOURCE="HED">AGENCY:</HD> National Highway Traffic Safety Administration (NHTSA), Department of Transportation (DOT). <HD SOURCE="HED">ACTION:</HD> Notice and request for comments on a new information collection. <SUM> <HD SOURCE="HED">SUMMARY:</HD> In compliance with the Paperwork Reduction Act of 1995 (PRA), this notice announces that the Information Collection Request (ICR) abstracted below will be submitted to the Office of Management and Budget (OMB) for review and approval. The ICR describes the nature of the information collection and its expected burden. The National Highway Traffic Safety Administration (NHTSA) intends to conduct a new information collection for a National Roadside Survey (NRS) of alcohol and other drug prevalence among drivers and other road users (ORUs; <E T="03">e.g.,</E> pedestrians, bicyclists, electric scooter riders, and those with mobility aids). NHTSA will conduct two studies. Study 1 will focus on drivers but include convenience sampling of ORUs passing by the driver data collection locations. Study 2 is a pilot test assessing the feasibility of an NRS specific to ORUs. Both will collect breath and oral fluid specimens, demographic information, and self-report questionnaire data on roads across the country. Participation will be voluntary and anonymous. A <E T="04">Federal Register</E> notice with a 60-day comment period soliciting comments on the following information collection was published on November 20, 2024. NHTSA received 6 comments, which we address below. </SUM> <DATES> <HD SOURCE="HED">DATES:</HD> Comments must be submitted on or before October 20, 2025. </DATES> <HD SOURCE="HED">ADDRESSES:</HD> Written comments and recommendations for the proposed information collection, including suggestions for reducing burden, should be submitted to the Office of Management and Budget at <E T="03">www.reginfo.gov/public/do/PRAMain.</E> To find this particular information collection, select “Currently under Review—Open for Public Comment” or use the search function. <FURINF> <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD> For additional information or access to background documents, contact Stacy Jeleniewski, Contracting Officer's Representative, Office of Behavioral Safety Research (NPD-310), <E T="03">stacy.jeleniewski@dot.gov,</E> National Highway Traffic Safety Administration, W46-491, 1200 New Jersey Avenue SE, Washington, DC 20590. </FURINF> <SUPLINF> <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD> Under the PRA (44 U.S.C. 3501 <E T="03">et seq.</E> ), a Federal agency must receive approval from the Office of Management and Budget (OMB) before it collects certain information from the public and a person is not required to respond to a collection of information by a Federal agency unless the collection displays a valid OMB control number. In compliance with these requirements, this notice announces that the following information collection request will be submitted to OMB. <E T="03">Title:</E> National Roadside Survey of Alcohol and Drug Prevalence of Road Users: 2025. <E T="03">OMB Control Number:</E> New. <E T="03">Form Numbers:</E> NHTSA Forms #1762, 1763, 1764. <E T="03">Type of Request:</E> Request for approval of a new information collection. <E T="03">Type of Review Requested:</E> Regular. <E T="03">Requested Expiration Date of Approval:</E> 3 years from date of approval. <E T="03">Summary of the Collection of Information:</E> NHTSA is seeking approval to conduct two studies. Study 1 will focus on drivers but include convenience sampling of ORUs passing by the data collection locations. Study 2 is a Pilot Test assessing the feasibility of an NRS specific to ORUs. Both will collect breath and oral fluid specimens, demographic information, and self-report questionnaire data on roads across the country. Participation will be voluntary and anonymous. Study 1 will recruit drivers at the roadside to test for alcohol and other selected drugs known, or suspected, to impair cognitive and motor skills important for driving safety. The study will operate data collection research teams across the country to collect breath samples, oral fluid specimens, and questionnaire data to be analyzed to achieve NHTSA's research objectives. The study will allow NHTSA to estimate the population-level prevalence of alcohol- and other drug-positive driving on roadways in the U.S. for the selected days and times. Information will also be requested from other road users who pass by the Study 1 data collection locations. Study 2 examines the viability of a stand-alone roadside nationwide survey focused solely on ORUs. This effort uses 20 new data collection locations, inclusive of 4 PSUs with 5 locations in each. This effort is to inform NHTSA on the feasibility of such a targeted roadside survey, and to determine the level of effort to execute a nationwide study of ORUs. The same procedures as Study 1 will be used. <E T="03">Description of the Need for the Information and Proposed Use of the Information:</E> NHTSA was established to reduce deaths, injuries, and economic losses resulting from motor vehicle crashes on the Nation's highways. As part of this statutory mandate, NHTSA is authorized to conduct research for the development of traffic safety programs. Subchapter V of Chapter 301 of Title 49 of the United States Code (U.S.C.) authorizes the Secretary of Transportation to conduct motor vehicle safety research. 49 U.S.C. 30182. Pursuant to Section 1.95 of Title 49 of the Code of Federal Regulations (CFR), the Secretary has delegated this authority to the National Highway Traffic Safety Administration (NHTSA). Additionally, Title 23, United States Code, Chapter 4, Section 403 gives the Secretary of Transportation (NHTSA by delegation) authorization to use funds appropriated to conduct research and development activities. The agency develops, promotes, and implements educational, engineering, and enforcement programs with the goal of ending preventable tragedies and reducing economic costs associated with vehicle use and highway travel. Current data is essential to develop appropriate approaches to improve traffic safety. This is especially true for information on impaired driving, both for alcohol, and for drug use and driving where data is much more limited. Drugs affect biology, perception, psychomotor ability, and behavior. With the exception of alcohol, however, relatively little is known about the prevalence of drugged driving currently on U.S. roadways because of the complexities associated with collecting, analyzing, and reporting information on other drug use. Given the number of States legalizing medicinal and/or recreational use of cannabis, and other issues such as the increase in opioid use in the U.S., more information is needed on the level of alcohol-involved and other drug-involved driving on the nation's roadways to better inform NHTSA's countermeasure development efforts. NHTSA and other traffic safety stakeholders have sought to learn about these issues through varied methodological approaches. For Study 1, researchers will collaborate with State and local officials to collect data at the roadside at 300 roadway locations (60 primary sampling units [PSUs], also known as “sites,” with 5 roadway locations each) across the country. Roadside surveys such as this provide objective measures of alcohol and other drugs in drivers' systems at the time they are actually driving, based on tests results from breath samples and oral fluid samples collected using established sample collection methods. All samples will then be tested, and results confirmed by a leading forensic toxicology laboratory. This approach will allow for the estimation of alcohol and other drug prevalence among the non-crash-involved general driving population in the U.S. for the selected days and times studied. Study 1 also explores whether it is possible to collect information from ORUs encountered at the driver data collection locations including individuals in transit on foot, on a bicycle, electric scooter, or with a mobility aid. Study 2 is a separate test to determine the viability of a stand-alone roadside survey focused solely on ORUs ( <E T="03">i.e.,</E> excluding drivers) to estimate the population level prevalence of alcohol and other drug use among other road user types for specified days and times. Study 2 will select 20 new data collection locations to recruit a convenience sample of ORUs. The results of this project will assist NHTSA as the agency develops its programmatic activities aimed at reducing crashes and fatalities that may be associated with the use of alcohol and/or other drugs. It is expected the results of this study will be compared to future studies to monitor alcohol and other drug prevalence trends over time on the nation's roadways. <E T="03">60-Day Notice:</E> A <E T="04">Federal Register</E> notice with a 60-day comment period soliciting public comments on the following information collection was published on November 20, 2024 (89 FR 43505). Five comments were received during the comment period; One additional comment was received the next day. The American Association of Motor Vehicle Administrators (AAMVA) expressed support for the project, stating they are “supportive of the opportunity to have greater transparency into safety data that can help roadway safety researchers and practitioners to better understand the prevalence of driv ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Preview showing 10k of 17k characters. Full document text is stored and available for version comparison. ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
This text is preserved for citation and comparison. View the official version for the authoritative text.